대학원

사경하 교수

사경하 교수

사경하 / Jason Kyungha Sa

  • 소속대학원 의학과
  • 직위조교수
  • 세부전공암유전체학
  • 연구실위치
  • 구내전화번호
  • 팩스
  • 이메일jasonksa@korea.ac.kr
학력사항
2005.09 -2009.06 University of California Santa Barbara, B.S.
2011.09- 2013.08 성균관대학교 삼성융합의과학원, M.S.
2013.09- 2017.02 성균관대학교 삼성융합의과학원, Ph.D
교육 및 경력사항
2017.01 - 2019.08 삼성서울병원 / 선임연구원
2019.09 - 현재 고려대학교 의과대학 대학원 / 조교수
대표논문
[Selected Publications]
● Park KH, Choi JY, Lim AR, Kim JW, Choi YJ, Lee S, Sung JS, Chung HJ, Jang B, Yoon D, Kim S,?Sa JK*, Kim YH* (2022) Genomic landscape and clinical utility of Korean advanced pan-cancer patients from prospective clinical sequencing: K-MASTER program, Cancer Discovery, 12(4):938-948
● Kim H*,?Sa JK*, Kim J, Cho HJ, Oh HJ, Choi DH, Kang SH, Jeong DE, Nam DH, Lee H, Lee HW, Chung S (2022) Recapitulated crosstalk between cerebral metastatic lung cancer cells and brain perivascular tumor microenvironment in a microfluidic co-culture chip, Advanced Science, Epub ahead of print
● Hong JY*, Cho HJ*, Sa JK*, Liu X*, Ha SY*, Lee T, Kim H, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Park HC, Kang TW, Rhim H, Lee SJ, Cristescu R, Lee J, Paik YH, Lim HY (2022) Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial, Genome Medicine, 14(1):1
● Kim ST*, Sa JK*, Oh SY*, Kim K, Hong JY, Kang WK, Kim KM, Lee J (2021) Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial, Genome Medicine, 13(1):11
● Hong JH*, Kang S*, Sa JK*, Park G*, Oh YT, Kim TH, Yin J, Kim SS, D'Angelo F, Koo H, You Y, Park S, Kwon HJ, Kim CI, Ryu H, Lin W, Park EJ, Kim YJ, Park MJ, Kim H, Kim MS, Chung S, Park CK, Park SH, Kang YH, Kim JH, Saya H, Nakano I, Gwak HS, Yoo H, Lee J, Hur EM, Shi B, Nam DH, Iavarone A, Lee SH, Park JB (2021) Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma, Brain, 144(2):636-654
● Sa JK*, Chang N*, Lee HW*, Cho HJ*, Ceccarelli M*, Cerulo L, Yin J, Kim SS, Caruso FP, Lee M, Kim D, Oh YT, Lee Y, Her NG, Min B, Kim HJ, Jeong DE, Kim HM, Kim H, Chung S, Woo HG, Lee J, Kong DS, Seol HJ, Lee JI, Kim J, Park WY, Wang Q, Sulman EP, Heimberger AB, Lim M, Park JB, Iavarone A, Verhaak RGW, Nam DH (2020) Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma, Genome Biology, 21(1):216
● Lee HW*, Sa JK*, Gualberto A, Scholz C, Sung HH, Jeong BC, Choi HY, Kwon GY, Park SH (2020) A phase II trial of tipifarnib for patients with previously-treated, metastatic urothelial carcinoma harboring HRAS mutations, Clinical Cancer Research, 26(19):5113-5119
● Sa JK*, Hong JY*, Lee IK, Kim JS, Sim MH, Kim HJ, An JY, Sohn TS, Lee JH, Bae JM, Kim S, Kim KM, Kim ST, Park SH, Park JO, Lim HY, Kang WK, Her NG, Lee Y, Cho HJ, Shin YJ, Kim M, Koo H, Kim M, Seo YJ, Kim JY, Choi MG, Nam DH, Lee J (2020) Comprehensive pharmacogenomics characterization of gastric cancer, Genome Medicine, 12(1):17
● Sa JK*, Hwang JR*, Cho YJ*, Ryu JY, Choi JJ, Jeong SY, Kim J, Kim MS, Paik ES, Lee YY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee Y, Her NG, Shin YJ, Cho HJ, Kim JY, Seo YJ, Koo H, Oh JW, Lee T, Kim HS, Song SY, Bae JS, Park WY, Han HD, Ahn HJ, Sood AK, Rabadan R, Lee JK, Nam DH, Lee JW (2019) Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers, Genome Biology, 20(1):253
● Shin YJ*, Sa JK*, Lee Y, Kim D, Chang N, Cho HJ, Son M, Oh YT, Shin K, Lee JK, Park J, Jo YK, Kim M, Paddison PJ, Tergaonkar V, Lee J, Nam DH (2019) PIP4K2A as a negative regulator of Phosphoinositide 3-Kinase signaling in PTEN-deficient glioblastoma, Journal of Experimental Medicine, 216(5):1120-1134
● Lee JK*, Liu Z*, Sa JK*, Shin S*, Wang J*, Bordyuh M, Cho HJ, Elliott O, Chu T, Choi SW, Rosenbloom DS, Lee IH, Shin YJ, Kang HJ, Kim D, Kim SY, Sim MH, Kim J, Lee T, Seo YJ, Shin H, Lee M, Kim SH, Kwon YJ, Oh JW, Song M, Kim M, Kong DS, Choi JW, Seol HJ, Lee JI, Kim ST, Park JO, Kim KM, Song SY, Lee JW, Kim HC, Lee JE, Choi MG, Seo SW, Shim YM, Zo JI, Jeong BC, Yoon Y, Ryu GH, Kim NKD, Bae JS, Park WY, Lee J, Verhaak RGW, Iavarone A, Lee J, Rabadan R, Nam DH (2018) Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy, Nature Genetics, 50(10):1399-1411
● Sa JK*, Kim SH*, Lee JK, Cho HJ, Shin YJ, Shin H, Koo H, Kim D, Lee M, Kang W, Hong SH, Kim JY, Park YW, Song SW, Lee SJ, Joo KM, Nam DH (2018) Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma, Neuro-Oncology, 21(2):222-233
● Lee JK*, Wang J*, Sa JK*, Ladewig E*, Lee HO, Lee IH, Kang HJ, Rosenbloom DS, Camara PG, Liu Z, Nieuwenhuizen PV, Jung SW, Choi SW, Kim JH, Chen A, Kim KT, Shin S, Seo YJ, Oh JM, Shin YJ, Park CK, Kong DS, Seol HJ, Blumberg A, Lee JI, Iavarone A, Park WY, Rabadan R, Nam DH (2017) Spatiotemporal genomic architecture informs precision oncology in glioblastoma, Nature Genetics, 49(4):594-599
기타사항(특허, 저서, fellowship, Awards 등)
[상훈]
2022.3 Korean Society for Neuro-Oncology Scientific Award

목록